Team Approach to Polypharmacy Evaluation and Reduction

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
ComorbidityMedication Therapy Management
Interventions
OTHER

TAPER program

Patients will be randomized to receive the TAPER program at study start or delayed intervention at 6 months.

Trial Locations (1)

L8P 1H6

McMaster University, Hamilton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Health Canada

OTHER_GOV

collaborator

The Labarge Optimal Aging Initiative

OTHER

collaborator

David Braley and Nancy Gordon Chair in Family Medicine

OTHER

collaborator

RxISK

INDUSTRY

lead

McMaster University

OTHER

NCT02562352 - Team Approach to Polypharmacy Evaluation and Reduction | Biotech Hunter | Biotech Hunter